![PDF) Clinical consequences of primary CMV infection after renal transplantation: a case‐control study PDF) Clinical consequences of primary CMV infection after renal transplantation: a case‐control study](https://i1.rgstatic.net/publication/341810038_Clinical_consequences_of_primary_CMV_infection_after_renal_transplantation_a_case-control_study/links/5f39995c299bf13404cb177d/largepreview.png)
PDF) Clinical consequences of primary CMV infection after renal transplantation: a case‐control study
![Evaluation of risk factors associated with drug-resistant tuberculosis in Yemen: data from centres with high drug resistance | BMC Infectious Diseases | Full Text Evaluation of risk factors associated with drug-resistant tuberculosis in Yemen: data from centres with high drug resistance | BMC Infectious Diseases | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12879-019-4069-1/MediaObjects/12879_2019_4069_Fig1_HTML.png)
Evaluation of risk factors associated with drug-resistant tuberculosis in Yemen: data from centres with high drug resistance | BMC Infectious Diseases | Full Text
![A polymeric approach toward resistance-resistant antimicrobial agent with dual-selective mechanisms of action | Science Advances A polymeric approach toward resistance-resistant antimicrobial agent with dual-selective mechanisms of action | Science Advances](https://www.science.org/cms/asset/94653487-094b-442f-9ce9-de0993f8a4be/abc9917-f1.gif)
A polymeric approach toward resistance-resistant antimicrobial agent with dual-selective mechanisms of action | Science Advances
![Improving CLL Vγ9Vδ2-T–cell fitness for cellular therapy by ex vivo activation and ibrutinib - ScienceDirect Improving CLL Vγ9Vδ2-T–cell fitness for cellular therapy by ex vivo activation and ibrutinib - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0006497120429908-grabsf1.jpg)
Improving CLL Vγ9Vδ2-T–cell fitness for cellular therapy by ex vivo activation and ibrutinib - ScienceDirect
![PDF] Mapping Factors that Drive Drug Resistance (with a Focus on Resource-Limited Settings): A First Step Towards Better Informed Policy | Semantic Scholar PDF] Mapping Factors that Drive Drug Resistance (with a Focus on Resource-Limited Settings): A First Step Towards Better Informed Policy | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/068859872ad8d4e2dde00d9d5d4b94bc802f9e5e/31-Table12-1.png)
PDF] Mapping Factors that Drive Drug Resistance (with a Focus on Resource-Limited Settings): A First Step Towards Better Informed Policy | Semantic Scholar
![Improving CLL Vγ9Vδ2-T–cell fitness for cellular therapy by ex vivo activation and ibrutinib - ScienceDirect Improving CLL Vγ9Vδ2-T–cell fitness for cellular therapy by ex vivo activation and ibrutinib - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0006497120429908-gr7.jpg)
Improving CLL Vγ9Vδ2-T–cell fitness for cellular therapy by ex vivo activation and ibrutinib - ScienceDirect
![Clinical consequences of primary CMV infection after renal transplantation: a case–control study - Singh - 2020 - Transplant International - Wiley Online Library Clinical consequences of primary CMV infection after renal transplantation: a case–control study - Singh - 2020 - Transplant International - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/ca023bb1-4953-48ae-a985-d0bc11fb38b3/tri.v33.9.cover.jpg?trick=1675841094122)
Clinical consequences of primary CMV infection after renal transplantation: a case–control study - Singh - 2020 - Transplant International - Wiley Online Library
![Improving CLL Vγ9Vδ2-T–cell fitness for cellular therapy by ex vivo activation and ibrutinib - ScienceDirect Improving CLL Vγ9Vδ2-T–cell fitness for cellular therapy by ex vivo activation and ibrutinib - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0006497120429908-gr3.jpg)
Improving CLL Vγ9Vδ2-T–cell fitness for cellular therapy by ex vivo activation and ibrutinib - ScienceDirect
![Clinical consequences of primary CMV infection after renal transplantation: a case–control study - Singh - 2020 - Transplant International - Wiley Online Library Clinical consequences of primary CMV infection after renal transplantation: a case–control study - Singh - 2020 - Transplant International - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/6616be93-6060-4b2c-a14a-346851bc2554/tri13667-fig-0001-m.jpg)
Clinical consequences of primary CMV infection after renal transplantation: a case–control study - Singh - 2020 - Transplant International - Wiley Online Library
![Improving CLL Vγ9Vδ2-T–cell fitness for cellular therapy by ex vivo activation and ibrutinib - ScienceDirect Improving CLL Vγ9Vδ2-T–cell fitness for cellular therapy by ex vivo activation and ibrutinib - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0006497120429908-gr1.jpg)
Improving CLL Vγ9Vδ2-T–cell fitness for cellular therapy by ex vivo activation and ibrutinib - ScienceDirect
![PDF] Mapping Factors that Drive Drug Resistance (with a Focus on Resource-Limited Settings): A First Step Towards Better Informed Policy | Semantic Scholar PDF] Mapping Factors that Drive Drug Resistance (with a Focus on Resource-Limited Settings): A First Step Towards Better Informed Policy | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/068859872ad8d4e2dde00d9d5d4b94bc802f9e5e/13-Figure2-1.png)
PDF] Mapping Factors that Drive Drug Resistance (with a Focus on Resource-Limited Settings): A First Step Towards Better Informed Policy | Semantic Scholar
![Improving CLL Vγ9Vδ2-T–cell fitness for cellular therapy by ex vivo activation and ibrutinib - ScienceDirect Improving CLL Vγ9Vδ2-T–cell fitness for cellular therapy by ex vivo activation and ibrutinib - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0006497120429908-gr4.jpg)
Improving CLL Vγ9Vδ2-T–cell fitness for cellular therapy by ex vivo activation and ibrutinib - ScienceDirect
![PDF) Rates of drug resistance and risk factor analysis in civilian and prison patients with tuberculosis in Samara Region, Russia PDF) Rates of drug resistance and risk factor analysis in civilian and prison patients with tuberculosis in Samara Region, Russia](https://www.researchgate.net/profile/Yanina-Balabanova/publication/8049803/figure/tbl1/AS:601770535448609@1520484684833/Prevalence-of-drug-resistance-in-new-and-previously-treated-civilian-cases-n-309-in_Q320.jpg)